A New Era for HFpEF Treatment: A Quick Guide for Pharmacists
2026 ACC HFpEF guidance expands treatment beyond diuretics, highlighting SGLT2 inhibitors, finerenone, obesity therapies, and BP management.
2026 ACC HFpEF guidance expands treatment beyond diuretics, highlighting SGLT2 inhibitors, finerenone, obesity therapies, and BP management.